All In Biotech

Free tool

FAERS Monitor: Humira

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125057 or its brand name (Humira, Adalimumab). Reports on generic versions are filed under their own applications.

Reports

707,206

Serious

361,046

51% of reports

Hospitalization

150,085

Death reported

30,552

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective92,025
  • pain49,968
  • arthralgia48,831
  • injection site pain47,452
  • fatigue39,903
  • rheumatoid arthritis36,391
  • headache28,969
  • nausea27,641
  • diarrhoea26,024
  • rash25,952
  • psoriasis25,015
  • pain in extremity24,719
  • joint swelling23,840
  • incorrect dose administered22,416
  • off label use22,386

Reports by year received

View as table
YearReports
20046,016
20055,447
20061,501
20073,876
200812,338
200918,064
20109,215
201119,373
201227,620
201324,116
201448,971
201553,592
201685,177
201737,237
201842,043
201945,997
202048,439
202139,138
202278,512
202341,341
202426,912
202521,078
202611,202

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,346,953 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rheumatoid arthritisSignal36,39113.613.4289,169
joint swellingSignal23,8407.17.0100,331
psoriasisSignal25,0156.86.7100,840
injection site painSignal47,4525.35.2140,422
arthralgiaSignal48,8313.83.891,708
incorrect dose administeredSignal22,4163.13.129,615
pain in extremitySignal24,7192.62.623,238
painSignal49,9682.52.544,344
drug ineffectiveSignal92,0252.22.156,708
rash25,9521.81.89,197
fatigue39,9031.61.57,732
headache28,9691.41.43,148
diarrhoea26,0241.21.2918
nausea27,6411.01.043
off label use22,3860.80.71,826

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.